Comprehensive Geriatric Assessment in Kidney Transplantation
Launched by INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE · Oct 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a thorough evaluation of older adults can help improve the outcomes for people aged 60 and above who are either waiting for a kidney transplant or have already received one. The goal is to understand how this assessment can help track and enhance their health and daily functioning.
To be a part of this study, participants need to be at least 60 years old and either waiting for a kidney transplant or have already had one. The trial is currently looking for participants, and anyone who meets these age requirements can join. If you decide to participate, you can expect to undergo a detailed health evaluation, which may help identify any issues that could affect your recovery or quality of life. This study is important because it aims to make kidney transplantation safer and more effective for older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • kidney transplant candidates aged 60+ years
- • kidney transplant recipients aged 60+ years
- Exclusion Criteria:
- • kidney transplant candidates aged below 60 years
- • kidney transplant recipients aged below 60 years
About Institute For Clinical And Experimental Medicine
The Institute for Clinical and Experimental Medicine (IKEM) is a leading research institution dedicated to advancing healthcare through innovative clinical and experimental studies. With a strong emphasis on translational research, IKEM aims to bridge the gap between laboratory discoveries and clinical applications, fostering collaboration among scientists, healthcare professionals, and industry partners. Its state-of-the-art facilities and multidisciplinary approach enable robust investigations into a wide range of medical conditions, ultimately striving to improve patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Praha, , Czechia
Patients applied
Trial Officials
Silvie Rajnochova Bloudickova, MD,PhD
Study Director
Department of Nephrology, Institute for Clinical and Experimental Medicine
Hana Vankova, MD,PhD
Principal Investigator
Third Faculty of Medicine Charles University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported